Jane Street’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Jane Street’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-17,988	Closed	-$190K	–	3392
2014 Q1	$190K	Buy	+17,988	New	+$257K	﹤0.01%	2392

Other funds holding OCRX

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Jane Street's OCRX Position: Q2 2014 in Review

Jane Street sold out of Ocera Therapeutics, Inc. (OCRX) in Q2 2014, closing a stake of 17,988 shares — an estimated $190K sold.

Jane Street first reported a position in OCRX in Q1 2014 and held it in 1 quarter. The position peaked at $190K in Q1 2014. 33 funds tracked by Wall St. Rank hold OCRX as of Q2 2014.

Jane Street reported no remaining Ocera Therapeutics, Inc. position as of Q2 2014 after selling out during the quarter.
Jane Street sold 17,988 Ocera Therapeutics, Inc. shares in Q2 2014, an estimated $190K.
Jane Street first reported a position in Ocera Therapeutics, Inc. in Q1 2014 and held it in 1 quarter.
Jane Street's Ocera Therapeutics, Inc. position peaked at $190K in Q1 2014.
33 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q2 2014.

Based on Jane Street's 13F filing for Q2 2014, filed 14 Aug 2014.